Mark Thrun is an Infectious Disease physician affiliated with Gilead Sciences. OpenAlex indexes 53 publications with 1,016 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingNIH funding
5 NIH research awards on record, funded 2006–2015 per NIH RePORTER. The latest:
- DENVER PREV TRNG CTR (PTC) CPCTY BLDG ASSISTNCE (CBA) FOR HLTH
Denver Health and Hospital Authority
FY2015$1,050,000U65PS004384 - DENVER PREV TRNG CTR (PTC) CPCTY BLDG ASSISTNCE (CBA) FOR HLTH
Denver Health and Hospital Authority
FY2014$1,050,000U65PS004384 - DENVER PTC APPLICATION FOR REGIONAL VIII STD CLINICAL TRAINING CENTER, NATIONAL COORDINATION CENTER, NATIONAL EVALUATION CENTER, AND NATL TECH INN CTR
Denver Health and Hospital Authority
FY2014$680,500U62PS004572
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Jared Baeten, MD
Gilead Sciences
Chuhan Chung, MD
Gilead Sciences
John McHutchison, MD
Gilead Sciences
James F. Rooney
Gilead Sciences
Thomas Walsh, MD
Cornell University
Douglas Richman, MD
University of California San Diego
Henry Masur, MD
National Institutes of Health
Vance Fowler, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”